drugset / Trial / NCT00142272

Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial

NCT00142272

RandomizedParallel-groupOpen-labelTreatment

Summary

The study will be conducted to compare the efficacy and safety of a single dose of ciprofloxacin oral suspension 20 mg/kg with a 3-day course of erythromycin oral suspension administered in a dose of 12.5 mg/kg every 6 hours (12 doses) in the treatment of children, aged 2-15 years with clinically severe cholera due to V. cholerae O1 or O139. We hypothesize that single dose ciprofloxacin would result in similar outcome in the clinicalcurewith that of erythromycin given in multiple doses.

Timeline

Start
2001-05
Primary completion
Completion
2002-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 20 mg/kg Oral

Indications